Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
33,166,548
-
Total 13F shares
-
2,025,076
-
Share change
-
+818,020
-
Total reported value
-
$2,978,156
-
Price per share
-
$1.43
-
Number of holders
-
25
-
Value change
-
+$1,156,195
-
Number of buys
-
10
-
Number of sells
-
4
Institutional Holders of Envoy Medical, Inc. - Class A Common Stock (COCH) as of Q4 2024
As of 31 Dec 2024,
Envoy Medical, Inc. - Class A Common Stock (COCH) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,025,076 shares.
The largest 10 holders included
Atlas Merchant Capital LLC, Weiss Asset Management LP, VANGUARD GROUP INC, DSG Capital Advisors, LLC, Focus Partners Wealth, GEODE CAPITAL MANAGEMENT, LLC, LAKE STREET ADVISORS GROUP, LLC, CIBC Private Wealth Group LLC, MORGAN STANLEY, and HighPoint Advisor Group LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.